Based on 4 analysts
In the current month, IMA has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IMA average Analyst price target in the last month is 18.000.
Based on analysts' estimates, IMA EPS is projected to reach -0.965 in FY2026Q4, following reported EPS of -0.910 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.91, while ImageneBio Ord ShsIMA's earnings per share (EPS) for the previous quarter was USD -0.63. EPS for the next quarter is expected at USD -0.97.